Skip to main content
Log in

Posaconazole tablets cost effective in patients with AML or MSD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 euros

Reference

  • Camara R, et al. Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain. Advances in Therapy : 14 Aug 2017. Available from: URL: http://doi.org/10.1007/s12325-017-0600-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Posaconazole tablets cost effective in patients with AML or MSD. PharmacoEcon Outcomes News 785, 29 (2017). https://doi.org/10.1007/s40274-017-4279-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4279-y

Navigation